Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.
Also called NCT01229566
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 240 participants
- Sponsor
- Trygg Pharma, Inc.
- Registry
-
NCT01229566
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT01229566. Randomized; quadruple masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2012-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia
- Condition
- Severe Hypertriglyceridemia
- Intervention (Drug)
- AKR-963
- Lead sponsor
- Trygg Pharma, Inc.
Record details
- Record id
cardio:ct-nct01229566- Content hash
ff0003977de3b05c26cbbe0565f78dcecfc2f55d4817402370ed3ef18748118c